Tag

immuno-rt

Early stereotactic radiotherapy was associated with longer progression-free survival in pancreatic cancer

Adding early stereotactic body radiotherapy to neoadjuvant chemoimmunotherapy was associated with median progression-free survival of 12.5 versus 6.6 months.

RadOncToday · 1 Jul 2026 ·1 min read

preliminary colorectal radioligand-therapy immuno-rt

Radiotherapy primes PDL1-targeted radionuclide therapy but splenic uptake limits efficacy

Radiotherapy increased tumor uptake of PDL1-targeted radionuclide therapy, while antibody co-dosing reduced splenic trapping and restored antitumor efficacy in mice.

RadOncToday · 26 Jun 2026 ·1 min read